Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 244 institutions that hold shares in the stock, with a total of 59.9 Million shares, which have been reported (via 13F filing form) to have a value of $2.02 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
5,674,466
shares
|
$200 Million
0.99% of portfolio
|
Q4 2024
Added 0.24%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
5,631,321
shares
|
$198 Million
0.0% of portfolio
|
Q4 2024
Added 1.54%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,859,002
shares
|
$171 Million
0.0% of portfolio
|
Q2 2024
Added 4.31%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
3,515,150
shares
|
$124 Million
2.3% of portfolio
|
Q4 2024
Reduced 5.91%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
2,423,537
shares
|
$85.4 Million
0.01% of portfolio
|
Q4 2024
Reduced 14.44%
|
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,264,304
shares
|
$79.7 Million
1.05% of portfolio
|
Q4 2024
Added 2.59%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,152,277
shares
|
$75.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.68%
|
|
|
Erste Asset Management Gmb H
Vienna, C4 |
Feb 10, 2025 Q4 2024 |
2,009,900
shares
|
$70.8 Million
0.81% of portfolio
|
Q4 2024
Reduced 8.01%
|
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
1,684,993
shares
|
$59.3 Million
0.06% of portfolio
|
Q4 2024
Reduced 0.34%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,500,000
shares
|
$52.8 Million
0.31% of portfolio
|
Q4 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,433,676
shares
|
$50.5 Million
0.01% of portfolio
|
Q4 2024
Added 12116.05%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,349,651
shares
|
$47.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.58%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,329,065
shares
|
$46.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 14.92%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,073,755
shares
|
$37.8 Million
1.32% of portfolio
|
Q4 2024
Reduced 9.78%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,069,754
shares
|
$37.7 Million
2.11% of portfolio
|
Q4 2024
Added 2.45%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,015,360
shares
|
$35.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 40.73%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Feb 05, 2025 Q4 2024 |
960,661
shares
|
$33.8 Million
0.01% of portfolio
|
Q4 2024
Added 12.31%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Feb 11, 2025 Q4 2024 |
942,189
shares
|
$33.2 Million
0.08% of portfolio
|
Q4 2024
Added 3.87%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
935,252
shares
|
$32.9 Million
0.01% of portfolio
|
Q4 2024
Added 39.67%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Feb 14, 2025 Q4 2024 |
917,420
shares
|
$32.3 Million
0.45% of portfolio
|
Q4 2024
Added 3.93%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
882,402
shares
|
$31.1 Million
0.03% of portfolio
|
Q2 2023
Added 26.77%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Feb 05, 2025 Q4 2024 |
683,463
shares
|
$24.1 Million
0.19% of portfolio
|
Q4 2024
Added 8.32%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
631,628
shares
|
$22.2 Million
0.03% of portfolio
|
Q4 2024
Reduced 50.0%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
627,036
shares
|
$22.1 Million
0.13% of portfolio
|
Q4 2024
Reduced 37.42%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
595,480
shares
|
$21 Million
0.0% of portfolio
|
Q4 2024
Added 0.91%
|